Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;27(13):2071-2080.
doi: 10.1177/1049732317732027. Epub 2017 Oct 3.

Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists

Molly M Lynch  1 , Jacqueline B Amoozegar  1 , Emily M McClure  1 , Linda B Squiers  1 , Cheryl S Broussard  2 , Jennifer N Lind  2 , Kara N Polen  2 , Meghan T Frey  2 , Suzanne M Gilboa  2 , Janis Biermann  3
Affiliations

Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists

Molly M Lynch et al. Qual Health Res. 2017 Nov.

Abstract

Our study sought to explore the actual and potential roles of patients, physicians, and pharmacists, as well as their shared challenges and opportunities, in improving the safety of medication use during pregnancy. We conducted virtual focus groups with 48 women and in-depth interviews with nine physicians and five pharmacists. Qualitative analysis revealed that all three groups of participants reported "playing it safe," the need for an engaged patient making informed decisions, challenges surrounding communication about pregnancy status, and a lack of patient-centric resources. Patients, physicians, and pharmacists are highly motivated to protect developing babies from potential harms of medication use during pregnancy while maintaining the patient's health. Strategic messaging could maximize the effectiveness of these interactions by helping physicians discuss the benefits and risks of medication use during pregnancy, pharmacists screen for pregnancy and counsel on medication safety, and patients using medications to share pregnancy intentions with their providers pre-pregnancy.

Keywords: United States; communication; decision making; doctor–patient; education; health; information seeking; nurse–patient; patient; pregnancy; qualitative; reproduction; triangulation.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2011;157:175–182. doi: 10.1002/ajmg.c.30313. - DOI - PubMed
    1. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 8. Philadelphia: Lippincott Williams & Wilkins; 2008.
    1. Crijns I, Mantel-Teeuwisse A, Bloemberg R, Pinas E, Straus S, de Jong-Van den Berg L. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: A descriptive study. Expert Opinion on Drug Safety. 2013;12:29–38. - PubMed
    1. Damase-Michel C, Christaud J, Berrebi A, Lacroix I, Montastruc JL. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiology and Drug Safety. 2009;18:1034–1038. - PubMed
    1. Denzin NK. Sociological methods. New York: McGraw-Hill; 1978.

MeSH terms